A detailed history of Sandy Spring Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Sandy Spring Bank holds 37,599 shares of ABBV stock, worth $6.65 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
37,599
Previous 37,608 0.02%
Holding current value
$6.65 Million
Previous $6.45 Million 15.12%
% of portfolio
0.31%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$163.84 - $199.33 $1,474 - $1,793
-9 Reduced 0.02%
37,599 $7.43 Million
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $150,610 - $175,879
-973 Reduced 2.52%
37,608 $6.45 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $217,035 - $247,291
-1,358 Reduced 3.4%
38,581 $7.03 Million
Q4 2023

Jan 26, 2024

SELL
$137.6 - $154.97 $569,113 - $640,955
-4,136 Reduced 9.38%
39,939 $6.19 Million
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $217,885 - $252,234
-1,631 Reduced 3.57%
44,075 $6.57 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $395,674 - $492,391
-2,986 Reduced 6.13%
45,706 $6.16 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $30,512 - $35,139
-211 Reduced 0.43%
48,692 $7.76 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $1.15 Million - $1.38 Million
8,300 Added 20.44%
48,903 $7.91 Million
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $381,961 - $438,084
-2,846 Reduced 6.55%
40,603 $5.45 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $104,453 - $132,794
-759 Reduced 1.72%
43,449 $6.66 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $263 - $327
-2 Reduced -0.0%
44,208 $7.17 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $20,196 - $25,554
188 Added 0.43%
44,210 $5.99 Million
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $178,858 - $203,031
-1,681 Reduced 3.68%
44,022 $4.75 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $88,376 - $98,456
840 Added 1.87%
45,703 $5.15 Million
Q1 2021

May 03, 2021

SELL
$102.3 - $112.62 $281,120 - $309,479
-2,748 Reduced 5.77%
44,863 $4.86 Million
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $75,580 - $102,041
-939 Reduced 1.93%
47,611 $5.1 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $26,030 - $30,551
-303 Reduced 0.62%
48,550 $4.25 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $136,394 - $182,516
1,859 Added 3.96%
48,853 $4.8 Million
Q1 2020

May 01, 2020

SELL
$64.5 - $97.79 $137,449 - $208,390
-2,131 Reduced 4.34%
46,994 $3.58 Million
Q4 2019

Feb 06, 2020

SELL
$72.13 - $90.25 $181,479 - $227,069
-2,516 Reduced 4.87%
49,125 $4.35 Million
Q3 2019

Nov 01, 2019

SELL
$62.98 - $75.72 $81,307 - $97,754
-1,291 Reduced 2.44%
51,641 $3.91 Million
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $448,665 - $573,499
-6,829 Reduced 11.43%
52,932 $3.85 Million
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $3.2 Million - $3.76 Million
-41,463 Reduced 40.96%
59,761 $4.82 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $623,734 - $769,232
-8,012 Reduced 7.33%
101,224 $9.33 Million
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $156,303 - $173,760
-1,758 Reduced 1.58%
109,236 $10.3 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $181,624 - $214,903
2,023 Added 1.86%
110,994 $10.3 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $65,695 - $87,971
-714 Reduced 0.65%
108,971 $10.3 Million
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $9,582 - $10,508
107 Added 0.1%
109,685 $10.6 Million
Q3 2017

Nov 03, 2017

SELL
$69.85 - $89.22 $93,319 - $119,197
-1,336 Reduced 1.2%
109,578 $9.74 Million
Q2 2017

Aug 11, 2017

BUY
N/A
110,914
110,914 $8.08 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.